Kara Watts, MD, envisions future trends in focal therapy for prostate cancer

In this video, Kara L. Watts, MD, shares her predictions for future trends in the arena of focal therapy. Watts is an associate professor of urology and the director of the Prostate Screening Program at Albert Einstein College of Medicine and Montefiore Medical Center in Bronx, New York.

Video Transcript:

There's a number of emerging modalities in the primary focal ablation space that are in trial at this time. So, I can envision that some of these will eventually extend into the salvage space as well as we develop more data in terms of subtotal therapy, both in the primary and in the salvage setting, with the goal of minimizing side effects. I do think that we will start to see longer term data for the current modalities that are in use for salvage ablation and probably some newer treatments that are currently being tested in the primary space emerging into the salvage space as well.

This transcript was AI generated and edited by human editors for clarity.